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Abstract— This paper describes a novel approach of detecting 
different stages of Alzheimer’s disease (AD) and imaging beta-
amyloid plaques and tau tangles in the brain using RF sensors. 
Dielectric measurements were obtained from grey matter and 
white matter regions of brain tissues with severe AD pathology at 
a frequency range of 200 MHz to 3 GHz using a vector network 
analyzer and dielectric probe. Computational models were 
created on CST Microwave Suite using a realistic head model 
and the measured dielectric properties to represent affected 
brain regions at different stages of AD. Simulations were carried 
out to test the performance of the RF sensors. Experiments were 
performed using textile-based RF sensors on fabricated 
phantoms, representing a human brain with different volumes of 
AD-affected brain tissues. Experimental data was collected from 
the sensors and processed in an imaging algorithm to reconstruct 
images of the affected areas in the brain. Measured dielectric 
properties in brain tissues with AD pathology were found to be 
different from healthy human brain tissues. Simulation and 
experimental results indicated a correlated shift in the captured 
reflection coefficient data from RF sensors as the amount of 
affected brain regions increased. Finally, images reconstructed 
from the imaging algorithm successfully highlighted areas of the 
brain affected by plaques and tangles as a result of AD. The 
results from this study show that RF sensing can be used to 
identify areas of the brain affected by AD pathology. This 
provides a promising new non-invasive technique for monitoring 
the progression of AD. 
 
Index Terms—Alzheimer’s disease, dielectric measurements, 
medical diagnosis, microwave imaging, radio frequency 
I. INTRODUCTION 
LZHEIMER’S disease (AD) is the most common form of 
neurodegenerative disease and is also the sixth leading 
cause of death in the United States [1]-[2]. According to the 
Alzheimer’s Association in U.S., AD is the most expensive 
disease in the U.S. compared to cancer and heart disease, with 
cost of care totaling an estimated $290 billion in 2019 [3]. AD 
is also the leading cause of death in women and the second 
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leading cause of death in men in the U.K. [4] The Alzheimer’s 
Society in the U.K. found that there are more than 520,000 
people with AD out of 850,000 suffering from dementia [5]. 
These numbers are expected to rise to 1 million by 2025.  
 Pathological changes in the brain that occur due to AD are: 
brain atrophy (or progressive shrinkage of the brain), 
particularly the hippocampus, and secondary lateral ventricle 
enlargement [6]. Histologically in AD the major change in the 
brain is the progressive accumulation of beta-amyloid plaques 
and tau neurofibrillary tangles [7]. Beta-amyloid proteins 
show up as irregular clumps in the brain that stick together to 
form plaques, interrupting the signals between synapses [8].  
Amyloid plaques initially develop in the neocortex and spread 
down through the brain in a characteristic fashion very early in 
the disease process [9]. In addition, neurofibrillary tangles 
formed of intracellular aggregates of tau protein are present in 
large numbers in the brain as AD progresses. These tangles 
interfere with the transport of cell nutrients and are thought to 
eventually contribute to the death of the neurons [8]. Tangles 
initially accumulate in the trans-entorhinal cortex and spread 
to the hippocampus and other brain regions as disease 
progresses [9]. Although the clinical phenotype of AD takes 
decades to develop, it is difficult to definitively diagnose AD 
until the clinical symptoms are advanced. In addition, early 
diagnosis of AD is not possible with current diagnostic scans, 
such as computed tomography (CT) and magnetic resonance 
imaging (MRI) scans [10]. 
 Beta-amyloid plaques and tau tangles are the definitive 
neuropathological lesions of AD [12]. As a result, researchers 
have focused on understanding the properties of plaques and 
tangles, and how they accumulate in the brain [12]-[13]. There 
are well-established markers of amyloid plaques using 
positron emission tomography (PET) scans in living people, 
where patients are injected with a radioactive substance that 
sticks to plaques and are highlighted in the resulting scan [14], 
and newer tau ligands are promising to track tangles in the 
living brain [15]. However, the high costs and invasive 
approach of PET scans makes it unsuitable for some to use 
[16]. In addition, PET scans have poor resolution, which 
potentially gives a misleading indication of the progression of 
AD pathology [8]. 
   It is therefore of paramount importance that other 
properties of plaques and tangles should be investigated, 
specifically, its dielectric properties. The dielectric properties 
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indicate how electromagnetic fields are transmitted, absorbed, 
and reflected in different biological tissues [17]. These 
properties, the relative permittivity and conductivity, are 
inherent characteristics of all tissues. Understanding these 
properties is therefore important for dosimetry studies, 
optimizing wireless telecommunication devices, and designing 
electromagnetic (EM) or radio frequency (RF) medical 
diagnostic devices [18]-[19].  
RF and microwave sensing technologies have been the 
focus of research for the past few years for medical 
applications. Several studies have been conducted on 
investigating and designing such devices for stroke and breast 
cancer detection. The authors have also previously 
investigated RF sensing for detecting brain atrophy and lateral 
ventricle enlargement [20]-[21]. These devices have the 
advantage of being low-cost, low-profile, and non-ionising; 
however, the translation into clinical use is still in its infancy.  
Several studies have also looked into dielectric properties of 
brain tumors and strokes; however, to the authors’ knowledge, 
there have been no studies reported on the measurement of 
dielectric properties for a brain with AD. Most recently, 
researchers have investigated the use of implantable antennas 
to detect presence of beta-amyloid proteins in cerebrospinal 
fluid (CSF) obtained from canines [22]. However, the 
implantable antenna is invasive and may not be convenient for 
patients to use.  
 This paper describes the investigation and development of a 
novel non-invasive approach to detect and image areas of the 
brain affected by plaques and tangles using RF sensors, that 
will ultimately be used to diagnose and monitor AD. The first 
part of this research focused on measuring and recording 
dielectric properties of human brain tissues with severe AD 
pathology, and comparing them to dielectric properties of 
healthy human brain tissues. Tissue samples were taken from 
a patient with severe AD and measurements were obtained on 
the gray matter and white matter portions using a vector 
network analyzer (VNA), dielectric probe, and PC. 
In the second part of this research, computational models 
were developed using measured dielectric properties of AD 
brain tissues to recreate different stages of AD (i.e. Mild 
Cognitive Impairment (MCI), Mild AD, Moderate AD, and 
Severe AD, respectively) inside a realistic head model. In 
addition, six ultra-wideband (UWB) antennas, that acted as RF 
sensors, were designed, optimized, and placed around the head 
model. Simulations were performed to investigate whether RF 
sensors could detect different levels of plaques and tangles in 
the brain based on the stage of AD.  
Finally, in the last part of this research, experiments were 
performed using flexible textile-based RF sensors on 
fabricated phantoms, representing a human brain with varying 
levels of brain tissues affected with plaques and tangles. Data 
was collected from the sensors and processed using the 
microwave imaging via space-time (MIST) beamforming 
algorithm, which was originally presented in [23], but 
specially modified in this research to adapt to the head and 
reconstruct the location and volume of AD-affected brain 
tissues detected in the brain.  
II. MATERIALS AND METHODS 
A. Dielectric Measurements 
Post-mortem brain tissue samples from a single patient with 
severe AD were obtained from the Edinburgh Brain Bank and 
used in the dielectric measurements. A total of 10 samples 
were utilized in the measurements, each with a dimension of 2 
cm x 1 cm x 1 cm. The samples were taken from the frontal 
cortex region of the brain and contained substantial amounts 
of beta-amyloid plaques and tau tangles, which were 
categorized as Braak stage C for amyloid plaques and 5 or 6 
for tau tangles, and Thal phase 1, which correlates to a severe 
progression of AD in the patient’s brain. Samples were 
handled inside a Category 2 biosafety cabinet in order to 
safely work with the samples and maintain its temperature and 
humidity throughout the measurements. The biosafety cabinet 
was equipped with temperature and humidity controllers to 
control the environment inside the cabinet where the samples 
were placed, specifically keeping the humidity low such that 
no moisture is generated in the samples. Measurements were 
taken on both the gray and white matter regions of the tissue 
samples in the temperature range of 12 to 18.4 °C. Fig. 1 




                                                                                                            
Fig. 1.  Selection of brain tissue samples used in dielectric 
measurements. 
 
Dielectric properties of the samples were determined by 
measuring the input reflection coefficient of the sample using 
the two-port VNA, HP8753C controlled by a laptop PC. 
Measurements were taken between 200 MHz and 3 GHz using 
an Agilent high-temperature dielectric probe 85070E-0020 
that was connected to the VNA and used to capture dielectric 
properties from the samples. A GPIB connector was used to 
connect the VNA with the laptop, and a software associated 
with the dielectric probe was utilized for capturing the 
dielectric properties from the probe. Fig. 2 shows the complete 
experimental setup that was used for the dielectric 
measurements which included the laptop, VNA, category 2 
biosafety cabinet, and the dielectric probe. 
Dielectric measurements were taken 15 times at 200 evenly 
distributed discrete frequency points. Measurements were 
taken on the gray matter and white matter areas respectively. 
Recorded dielectric measurements of AD brain tissues at each 
frequency were then averaged using a built-in software and 
compared to those obtained from healthy brain tissue samples 
reported in [25] and [26]. White matter measurements 
obtained in [25] were between the frequency range of 10 Hz to 
20 GHz and were conducted ex- vivo on tissue samples that 
were obtained between 24- and 48-hours post mortem. 
 
 
Fig. 2. Dielectric measurement setup showing the VNA, 
laptop, biosafety cabinet, and dielectric probe used. 
 
The temperature of the tissue samples during the 
measurements were at body temperature (37℃). Gray matter 
dielectric measurements obtained in [26] were performed 
between the frequency range of 800 MHz to 2.45 GHz. The 
measurements were conducted on a brain specimen that was 
obtained from an adult human less than 10 hours after death. 
The measurements were performed ex-vivo and the mean 
temperature of the tissue during the measurements was 
21.45 ± 1.6℃. Results and comparisons between the 
measurements performed in this study are reported in Section 
III-A and shown in Figs. 12 and 13. 
B. Four-Pole Cole-Cole Model  
Complex relative permittivity of biological tissues is 
frequency-dependent and characterized by the following 
equation [24]: 
 
                          (𝜔) = ′(𝜔) − 𝑗 ′′(𝜔)                         (1) 
 
where ′(𝜔) is the real part known as relative permittivity, 
′′(𝜔) is the imaginary part known as loss factor, and 𝜔 is the 
angular frequency in rad/s. The real part of (1) defines the 
ability of the tissue to store energy from electromagnetic 
fields, whereas the imaginary part indicates the dissipation of 
energy into heat by frictional motion of elements carrying 
charges [25]. As a result, the imaginary part is also related to 
conductivity by the following: 
 
                         ′′(𝜔) =
𝜎
𝜀0𝜔
                                             (2) 
 
where 𝜎 is the conductivity and 0 is the permittivity of free-
space and equals to 8.8854  10-12 F/m. Dielectric properties 
of biological tissues are frequency dependent and vary across 
any given frequency range [26]. In the microwave frequency 
range, permittivity tends to decrease while conductivity tends 
to increase with respect to frequency. This variation in 
complex permittivity is called dispersion curve for the 
permittivity and absorption curve for the loss factor [24]. 
Typically, in order to represent the dispersion and absorption 
curves, the complex permittivity needs to be modeled using a 
dielectric model, such as the Debye or Cole-Cole model. A 
multi-pole or higher order model is recommended to fit the 
inhomogeneous and heterogeneous tissues because the single 
order dielectric models may not fit the complex human tissues 
[25]. A fourth order model is shown to provide a good fitting 
for tissues [26]. The four-pole Cole-Cole model for dielectric 
properties ( 𝐶(𝜔)) is defined as: 
 
 𝐶(𝜔) = 𝐶
′ (𝜔) − 𝑗 𝐶
′′(𝜔)            










                                                                                               (3)   
where 𝜏𝑖 is the relaxation time, 𝛼𝑖 is the exponent describing 
the dispersion regions, and 𝜎𝑠 is the static conductivity. The 
magnitude of the dispersion is represented by ∆ 𝑖 = 𝑠𝑖 − ∞, 
where 𝑠𝑖 is the static permittivity when 𝜏𝑖 ≪ 1/𝜔, and ∞ is 
the infinite permittivity when 𝜏𝑖 ≫ 1/𝜔. 
In this paper, the four-pole Cole-Cole model was used to fit 
the measured dielectric properties for gray matter and white 
matter regions of both AD and healthy tissue sample sets 
respectively. Estimation and optimization of the four-pole 
Cole-Cole model parameters were carried out using the Curve 
Fitting Toolbox in MATLAB. Table IV shows the list of four-
pole Cole-Cole model parameters that were obtained for each 
of the measured sample sets. 
C. Simulation Models 
After obtaining the dielectric measurements, computational 
models were developed in CST Microwave Studio Suite. A 
realistic human head voxel model, initially reported in [27], 
was used and modified in CST. Fig. 3 shows the CST head 
voxel model and cross-sectional view of the head model that 
illustrates the different regions, tissues, and geometries that 
were implemented in the model. 
 
 
               (a)            (b) 
Fig. 3. (a) Realistic human head model used for simulations in 
CST, and (b) cross-sectional view of the human head model 
showing the different layers, tissues and geometries of the 
brain.  
 
 The head model contained geometries and materials that 
were defined to represent different regions, tissues, and 
ventricles that are present in the brain. In addition, the model 
portrayed a realistic representation of the human head with 
different layers, such as skin, skull (bone), cerebrospinal fluid 
(CSF), gray matter and white matter. The advantage of the 
model was that the properties of individual areas or tissues 
could be controlled and modified for different conditions. The 
model proved to be useful in particular for defining certain 
areas of the brain that contain plaques and tangles during 
different stages of Alzheimer’s disease.  
In order to represent each stage of AD in the simulations, 
the dielectric properties of certain regions and tissues were 
changed to match those obtained from the dielectric 
measurements on the tissues. Table I lists the regions of the 
brain that were affected by AD in each stage and the 
 
corresponding dataset that was used to represent the plaques 
and tangles. Some of the cases required both the gray matter 
and white matter regions to be changed as both sets of tissues 
were found to be affected by AD in those stages based on the 
work by Braak in [28]. 
Fig. 4 (a)-(d) shows the simulation models that were created 
to represent the four different stages of AD, namely mild 
cognitive impairment (MCI), mild AD, moderate AD, and 
severe AD, respectively. In addition, each of these stages, with 
the exception of MCI, are based on the progression and 
location of amyloid plaques and tau tangles in the brain as a 
result of AD, that was originally presented by Braak in [28]. 
MCI has been defined in some follow up studies [29, 30] to be 
the earliest known stage where plaques and tangles start to 
form in the hippocampus region of the brain and are 
characterized as either Braak stage 0, 1, 2, before spreading to 







Fig. 4. Simulation models used to represent the amount of 
plaques and tangles (highlighted in blue) for the following 
stages of AD: (a) MCI, (b) Mild AD, (c) Moderate AD, and 
(d) Severe AD. 
 
The RF sensor that was designed and used in the models, is 
an ultrawideband (UWB) antenna, with an operating 
frequency of 1.5 GHz that is shown in Fig. 5. A 0.1-mm-thick 
flexible conductive textile, Shieldex Zell is utilized as the 
conducting material of the sensor, while the substrate is made 
of RS-PRO Viscose Wool Felt material with a measured 
relative permittivity, 𝑟 and loss tangent, 𝑡𝑎𝑛 𝛿 of 1.55 and 
0.068 respectively. The RF sensor is fed with a microstrip line 
where the line is then transitioned into a stepped monopole 
structure. To simultaneously improve the directionality and 
the bandwidth of the sensor, three rectangular shaped patches 
of different sizes are incorporated into the design. The patches 
are then excited by the stepped monopole structure to yield 
wideband performance.  
Parametric optimizations were carried out to find the 
optimal size of the patches. The final dimensions of the sensor 
are (in mm): L = 85, W = 35, Wf = 17, Lsm = 10, Wsm = 7, Ws1 
= 13, Ws2 = 20, Ws3 = 27, Ws4 = 30, Lt  = 15,   Lf  = 12, Lc = 14, 




Fig. 5. Geometry of the proposed textile antenna: a) Top view, 
b) Bottom view, and c) Isometric view. 
The intended band of operation for the sensor is between 1.3 
to 4.2 GHz. The ideal operating frequency band between 1.5 
and 2.1 GHz was found based on E-field distribution 
simulations as shown in Fig. 6. It can be observed in Fig. 6 
that at 1.5 and 2.1 GHz, the proposed sensor can achieve 
sufficient penetration depth that allows RF waves to reach the 
medial temporal lobe, where early signs of AD can occur. This 
is different from the E-field distribution at 4 GHz, where the 
propagated waves can only penetrate to the gray matter layer. 
For considering directionality, an important factor is the front-
to-back (FTB) ratio which indicates the ratio of power 
transmitted in the forward direction and power radiated in the 
backward (or opposite) direction. Although the sensor would 
operate mostly in near-field environment, the FTB criteria is 
still valid to ensure that the sensor could suppress any signals 
coming from its surroundings and mainly focus on the signals 
TABLE I 
REGIONS OF HEAD MODEL USED FOR STAGES OF ALZHEIMER’S DISEASE  
Stage 
 
Brain Region Affected 
        
Dataset Used 
MCI Medial Temporal Lobe 
 

























AD White  
AD White and AD Gray  
AD White and AD Gray  
 
AD White 
AD White and AD Gray 
AD White and AD Gray 
AD White and AD Gray 
 
AD White 
AD White and AD Gray 
AD White and AD Gray 
AD White and AD Gray 




(a) (b) (c) 
coming from the head. The simulated FTB ratio of the 
proposed sensor at its center frequency is 6 dB, thus 
confirming its directional characteristic. 
 
              
 
Fig. 6. Simulated E-field distribution of the proposed sensor 
inside the head at: a) 1.5 GHz, b) 2.1 GHz, and c) 4 GHz.   
  
For the simulation model, 6 RF sensors were placed around 
the head model and used to capture the reflection coefficient 
for each area of the brain as shown in Fig. 7. For each case, 
S11 data was captured for each sensor. Then the 6 sets of S11 
data were averaged in order to generate a mean S11 plot for 
each case and determine how the progression of plaques and 
tangles in the brain affects S11 data. 
 
 
Fig. 7. Simulation model setup showing the 6 RF sensors 
placed around the realistic head model in CST. 
D. Experimental Setup 
The system setup that was used for experiments is shown in 
Fig. 8. The experimental setup consists of a PC, VNA, 
wearable textile-based RF sensors, and the skull model which 
contains the fabricated phantoms. Fig. 9 (a)-(b) shows the 
textile-based RF sensor that was used in the experiments and 
the hat-like structure it was integrated in. To avoid having the 
sensors come into contact directly with the head, another felt 
material was placed on the sensor to act as a superstrate. This 
would help to minimize errors that may occur from the 
presence of hair or sweat. Due to the low loss tangent of the 
felt material and proximity of the antenna to the head, the 
propagated RF waves are not affected in the near field and is 
found to penetrate through the skull model and into the brain. 
The experiments were conducted using a host PC that was 
connected to the VNA via a GPIB. The PC allows the user to 
setup the VNA and send a command to the VNA to start 
generating signals and capturing S11 and S21 data from the 
ports directly into the PC using a built-in software. The VNA 
that was used for the experiments is a HP 8753 that has a 
frequency range of 300 kHz to 3 GHz with a dynamic range of 
up to 100 dB. The RF sensors were connected to the 50-ohm 
ports on the VNA using SMA cables. 
 
 
Fig. 8. Experimental setup used to test RF sensors on different 
levels of plaques and tangles.  
 
 
              
                     (a)                                        (b) 
Fig. 9. (a) Fabricated textile-based RF sensor used in the 
experiments, and (b) Hat-like structure containing the 6 RF 
sensors used in the experiments. 
 
A set of artificial brain phantoms were fabricated based on 
a method given in [11]. Each phantom contains 3 layers: a 
gray matter layer, white matter layer, and a target object of 
varying sizes that represent AD-affected brain tissues. To 
recreate an artificial replica of an average adult human brain 
with dielectric properties of gray matter and white matter, 
each layer had to be fabricated separately. For the gray matter 
region, 1400 mL of tap water was collected. Since water has a 
high dielectric constant, sugar was dissolved in the water to 
lower the dielectric constant of the mixture. Once the ideal 
mixture of sugar and water was reached, the mixture was 
boiled with 100 g agar powder. Once boiled, the solution was 
poured into the skull model and left to cool for a few hours in 
order for the mixture to solidify. Once solidified, cutting tools 
were used to carve out the central part of the phantom and 
leave 0.8 cm of the outer layer that covers the inner side of the 
skull.  
Next, to create phantoms representing AD-affected brain 
tissues, coconut oil and salt were mixed together. Dielectric 
properties of the mixture was measured until it reached the 
measured properties of AD white matter tissue samples. It was 
found that the dielectric property of the fabricated AD-
affected phantoms was 1.08% lower than the measured 
dielectric properties of the AD white matter tissues across the 
whole frequency band, making it a suitable representation of 
the AD-affected brain tissues for the experiments. The mixture 
was then cooled in order to solidify it. After the AD-brain 
tissue phantom solidified, it was carefully placed in the 
carved-out area of the gray matter layer. Finally, the white 
matter layer was created using the same method for the gray 
matter layer, ensuring that the water and sugar mixture has a 
 
similar dielectric property as obtained in the dielectric 
measurements. The mixture was then boiled with 100 g of 
agar and poured into the empty space inside the skull model 
such that it covers the AD-affected brain tissue object inside 
the phantom. It was then left to cool for a few hours in order to 
solidify and stick to the existing gray matter layer. Fig. 10 (a) 
shows an example of the fabricated phantoms used in the 
experiments and (b) shows the cross-sectional view of the 
fabricated phantom with the gray matter layer (blue), white 
matter layer (red), and embedded plaques and tangles object 
(white). 
To ensure that the fabricated gray matter and white matter 
layers had the correct dielectric constant, dielectric 
measurements were taken for the water and sugar mixture in 
the liquid stage, until it was within 2% of the actual values. 
This is because the addition of agar had to be taken into 
consideration as a potential effect on the dielectric constant.  
Once solidified, the total volume for the phantom would equal 
1400 mL, which corresponds to the total brain volume of an 
average adult human [10]. A final dielectric measurement was 
taken of the gray and white matter layers of the brain phantom 
after it solidified. It was found that measured dielectric 
properties of the fabricated gray matter phantom was 1.13% 
lower than those of the healthy brain tissue’s gray matter 
region across the whole frequency band. In addition, the 
measured dielectric properties of the fabricated white matter 
phantom was 1.56% lower than those of the healthy brain 
tissue’s white matter region across the whole frequency band. 
As a result, these phantoms are both suitable representations 
of the actual gray and white matter regions respectively. Table 
II below shows the composition of materials used to fabricate 
the phantoms. In addition, Table III provides the percentage 
change in the dielectric properties between the phantoms and 
actual tissues at certain frequency points.  
 
 
In order to emulate the spread of plaques and tangles in the 
brain, a total of 5 phantoms were created, each with varying 
volumes of AD-affected brain tissue phantom embedded in the 
2-layer brain phantom. The volumes of the AD-affected brain 
tissue phantom in each case are the following: 1) 0 mm3 
(healthy case), 2) 22.6 mm3, 3) 56.5 mm3, 4) 113 mm3, and 5) 
226 mm3.  
 
      
                 (a)                                       (b) 
 
Fig. 10. (a) Fabricated human brain phantom used in the 
experiments, and (b) Cross-sectional view of the phantom 
showing the gray matter (blue), white matter (red), and AD-
affected tissue object (white) embedded in the phantom. 
 
To perform the experiments, first the normal brain phantom 
(i.e. without the embedded AD-affected tissue objects) was 
inserted in the skull model and S11 measurements were 
captured for each RF sensor and averaged in order to capture 
the reference dataset for a model with no plaques/tangles. This 
reference dataset would be used later when reconstructing 
images for the experimental cases. Next, each of the phantom 
with the embedded plaques/tangles object (i.e., 22.6 mm3, 56.5 
mm3, 113 mm3, and 226 mm3) is placed in the skull model. 
Subsequent S11 data was collected from each RF sensor and 
averaged. This data is then processed in the imaging algorithm 
to reconstruct the images associated with the experimental 
case.  
E. Imaging Algorithm 
After the experiments, S11 data was used to recreate images 
of AD-affected brain tissue phantoms in the skull model for 
each case. The imaging algorithm used in this paper was a 
modified version of the microwave imaging via space-time 
(MIST) beamforming algorithm that was presented in [23] and 
shown in Fig. 11.  
 
 
Fig. 11. Block diagram illustrating the MIST beamforming 
process. 
 
In this algorithm, each antenna, or in this case, RF sensor, 
sequentially illuminates the head region with an UWB pulse 
signal and records the backscattered data. The space-time 
beamformer first time-shifts the returned signals to align them 
from a particular point in space. The time-aligned signals are 
then passed through a finite-impulse response (FIR) filter and 
summed to obtain the beamformer output. The result is time-
gated and the energy for the point of interest is calculated.  
TABLE II 











Gray Matter 1400 510 0 0 100 
White Matter  1400 730 0 0 100 
AD-Affected 
Tissue Object 
0 0 700 60 0 
   
 
 TABLE III 
PERCENTAGE CHANGE OF MEASURED DIELECTRIC PROPERTIES 
BETWEEN PHANTOMS AND ACTUAL TISSUES  
Phantom 0.2 GHz 1 GHz 2 GHz 3 GHz 
Gray Matter -0.83 -1.04 -1.11 -1.2 
White Matter  -1.4 -1.72 -1.34 -1.64 
AD-Affected 
Tissue Object 
-1.16 -0.89 -0.94 -1.05 





FOUR-POLE COLE-COLE MODEL PARAMETERS ACROSS 0.2 TO 3 GHZ  




















































               
 
 
In order to correctly highlight the areas of the brain 
containing the AD-affected brain tissues object, a reference 
image matrix was generated for the skull model that only 
contains the healthy brain phantom and no plaques/tangles 
objects. This image matrix is then subtracted from the image 
matrices generated for each experiment case to filter the data 
associated with the healthy brain phantom. The remaining data 
that is present in the image matrices therefore corresponds to 
the AD-affected brain tissue object that is in the skull model. 
An energy map is created utilizing all the beamformer outputs, 
further iterations are conducted to enhance the objects’ image 
and filter noise, and the location of AD-affected brain tissues 
are highlighted in the resulting image.  
The original MIST algorithm that was reported in [23] was 
used for breast cancer detection; therefore, it was not suitable 
to use for the purpose of head imaging due to differences in 
the location of the antennas used in the original algorithm, and 
resulting time delay that was derived. However, in order to 
modify this algorithm to use in head imaging, the RF sensors’ 
location had to be updated to match with those used in the 
experiments, where 6 RF sensors were placed around the 
circumference of the head. By updating the sensors’ location, 
the calculated time shift for each returned signal is changed to 
match with the distance associated with the sensor on the 
head. As a result of this slight modification, the modified 
MIST algorithm is capable of correctly aligning the 
backscattered signal data from the head with the correct time 
shift and reconstruct images in the head. 
III. RESULTS AND DISCUSSION 
A. Dielectric Measurement Results 
Dielectric properties of the samples were measured and 
compared with those of healthy human brain sample. Fig. 12 
shows the plot of the relative permittivity (real and imaginary) 
of the gray matter region of AD-infected brain tissue as 
compared to those of gray matter from a healthy human brain.  
The mean and standard deviation of the measured datasets for 
gray matter are provided in Table III. 
Analyzing the trends of the relative permittivity plots, there 
is a clear distinction between the gray matter readings from a 
healthy brain and a brain with AD. For instance, at 770 MHz, 
the real part of the relative permittivity is 56.434 for gray 
matter in a healthy brain and 44.89 for gray matter in the AD-
infected brain, which represents a 20.46% decrease in the real 
part of the relative permittivity.  
 
 
Fig. 12. Measured dielectric constant (real and imaginary) of 
gray matter section of AD vs. healthy human brain tissue. 
 
At 2.4 GHz, the real part of the relative permittivity is 
54.263 for gray matter in the healthy brain and 42.939 for gray 
matter in the AD-infected brain. The relative permittivity is 
slightly lower, but the percentage of change at this frequency 
is 20.87%, which is similar to that found in 770 MHz. It can 
be concluded that AD-infected brain sample has a lower 
relative permittivity compared to that of a healthy brain 
sample. In addition, it can also be seen that the imaginary part 
of the relative permittivity for gray matter is higher for the 
brain with AD compared to the healthy brain. For instance, at 
2.4 GHz, there is a 16.17% increase in the value for the 
imaginary part of the relative permittivity for gray matter in 
the brain with AD. 
In addition to understanding the effects of plaques and tangles 
on gray matter, it is also important to investigate its effects on 
white matter since that layer would get affected first by 
plaques and tangles before spreading to the gray matter layer 
of the brain. Fig. 13 shows the plot of measured relative 
permittivity (real and imaginary) for the white matter region of 
AD-infected brain samples and compared to the measurements 
for the white matter region of healthy brain tissue samples. 
The mean and standard deviation of the measured datasets for 
white matter are provided in Table V. Analyzing the relative 
permittivity plots in Fig. 13, a visible trend shows that there is 
a similar difference in the relative permittivity data across the 
frequency spectrum for the white matter region as in gray 
 
TABLE V 
STATISTICAL ANALYSIS OF MEASURED DIELECTRIC CONSTANTS  










43.612 ±2.2700 15.9041 ±4.9033 
Gray Matter 
-Healthy 
55.455 ±2.7066 12.9433 ±3.6475 
White Matter 
-AD 
32.610 ±1.5320 12.6695 ±3.841 
White Matter 
-Healthy 
39.064 ±1.9958 7.6695 ±3.7356 





matter. For example, at 770 MHz the relative permittivity is 
40.138 for white matter in the healthy brain and 32.32 for 
white matter in the AD-infected brain, which corresponds to a 
19.48% decrease in the relative permittivity.  
 
 
Fig. 13. Measured dielectric constant (real and imaginary) of 
the white matter section of AD vs. healthy human brain tissue. 
 
At 2.4 GHz, the relative permittivity is 37.517 for white 
matter in the healthy brain, and 31.824 for white matter in the 
AD-infected brain, corresponding to a 15.17% change. As in 
the plots for gray matter results, there is a decrease in relative 
permittivity between the healthy brain sample and AD-
infected brain samples. In addition, a similar trend can be seen 
for the imaginary part of the relative permittivity for white 
matter, as in the gray matter measurements, where there is an 
increase in the imaginary part value for white matter in a brain 
with AD compared to white matter from the healthy brain. For 
instance, at 2.4 GHz, there is a 44.88% increase in the value 
for the imaginary part for white matter in the brain with AD. 
In order to represent the measured dielectric properties in 
terms of the four-pole Cole-Cole model (Eq. 3), the Curve 
Fitting Toolbox in MATLAB was used to estimate and 
optimize all the parameters of the model to each of the 4 
measured datasets (i.e., Gray Matter-AD, Gray Matter-
Healthy, White Matter-AD, and White Matter-Healthy). The 
estimated four-pole Cole-Cole model parameters for each 
tissue in the measurements is given in Table IV. 
B.  Simulation Results for RF Sensors 
  Simulations for different stages of AD were also conducted 
and results were analyzed. Fig. 14 shows changes in S11 plots 
obtained from simulations between a healthy brain model, 
with a mean ± standard deviation of −6.9392 ± 5.1699, and 
brain models having properties of MCI, Mild AD, Moderate 
AD, and Severe AD as discussed in Section II-B. The 
reflection coefficient is a property of electromagnetic-based 
sensors that detects the amount of reflected electromagnetic 
waves that are received by the sensor. 
 
 
Fig. 14. Changes in S11 signals obtained from simulations for 
different stages of AD compared to S11 for a healthy brain. 
 
As the disease progresses in the brain, the amount of plaques 
and tangles spread to other regions of the brain. This results in 
the S11 plots showing an increasing downward-shift in the 
reflected signal in the operating frequency range of 1.5 to 2.1 
GHz, which indicates an increased loss in the signal. This is 
due to the dielectric changes occurring between the healthy 
brain and those representing different stages of AD. In 
particular, it can be seen that the change in S11 loss increases 
from −21.97 dB in MCI case to −34.54 dB in the Severe AD 
case at 1.901 GHz. In addition, it should be noted that in the 
case of Mild AD, where plaques and tangles affect the medial 
temporal, temporal, and parietal lobes, the plot shifts to the left 
by about 0.2 GHz. This is due to the averaged data collected 
from RF sensors placed around the head model. The sensors 
closest to the affected regions will generate higher losses, 
whereas those placed on the head in the frontal lobe and 
occipital lobe regions, will generate less loss across the 
frequency range, due to those regions having healthy tissues. 
Due to the low relative permittivity and high conductivity of 
brain tissues with AD, electromagnetic waves generated by the 
sensors are not reflected back easily as they pass through the 
infected areas of the brain. Instead, they tend to propagate 
more freely, thus causing a downward shift in the S11 plots. 
This validates the sensors’ ability to differentiate different 
stages of AD by detecting accumulation of plaques and tangles 
in the reflection mode. 
C. Experimental Results for RF Sensors 
Experiments were performed to validate the RF sensors in 
detecting increasing levels of AD-affected tissues in the brain 
as detailed in Section II-C. The resulting S11 plot is shown in 
Fig. 15. The S11 plot for a healthy brain has a mean ± standard 
deviation of −10.0821 ± 5.9123. Results in Fig. 15 shows a 
similar trend found in the simulation results where the S11 loss 
increases as a result of increasing volumes of AD-affected 
brain tissue phantom, due to changes in the dielectric 
properties as a result of plaques and tangles. It can be seen that 
at 1.8 GHz, the change in S11 increases to more than double, 
from -19.08 dB for 22.6 mm3 of AD-affected tissues, to -40.9 




Fig. 15. Changes in S11 signals obtained from experiments for 
increasing volumes of plaques and tangles in the brain 
phantom compared to S11 with no plaques and tangles.  
 
Similar trends can be seen in the operating frequency range 
of the antenna between 1.5 to 2.1 GHz, which matches the 
results from the simulation as well. It is also worth noting that 
as the AD-affected tissue volume increases inside the brain 
phantom, there is more change in the S11 loss measured 
outside the operating frequency range. For example, at 1.30 
GHz, the change in S11 increases from -10.46 dB for 22.6 mm3 
to -18.62 dB for 226 mm3 of AD-affected tissues in the brain 
phantom. This indicates the progression of plaques and tangles 
in the brain as the disease “spreads” to other regions, thus 
providing a promising validation of the sensors’ capability in 
detecting and monitoring the progression of AD in the brain. 
The last part of this paper will utilize the measured reflection 
coefficient signals in the modified MIST algorithm in order to 
reconstruct images of the plaques and tangles in the brain 
phantom.  
D. Image Reconstruction Results 
The reflection coefficient data was collected and used as an 
input to the MIST algorithm that was implemented in 
MATLAB. Fig. 16 shows the resulting images that were 
reconstructed for the four different levels of plaques and 
tangles in the brain (i.e., 22.6 mm3, 56.5 mm3, 113 mm3, and 
226 mm3 respectively). 
It can be seen in the resulting images that there is a 
correlation between the size of the red areas, as the size of the 
AD-affected tissues increases. As more plaques and tangles 
are accumulated, the radius of the highlighted area increases 
as well and the central area of the affected tissues is denser (as 
can be seen in the dark red color in the reconstructed images, 
thus signifying the volume of the AD-affected tissues. The 
reconstructed images also show the locations of brain tissues 
affected by plaques and tangles accurately. The resulting 
images are promising and further work will be done in 
optimizing this algorithm and utilizing a multistatic approach 
to generate clearer and more accurate images from the sensors. 
IV. CONCLUSION 
Dielectric measurements were captured for AD brain tissue 
samples and compared with measurements from healthy brain 
tissue samples. Results indicate that in both gray and white 
matter, the accumulation of beta-amyloid plaques and tau 
tangles in the brain caused a shift in the real and imaginary 
parts of the dielectric constant. Simulations and experiments 
were performed to verify whether RF sensors can be used to 
detect different stages of AD based on the accumulation of 
plaques and tangles in the brain. Results confirmed that the 
designed RF sensors are capable of distinguishing varying 
levels of AD-affected tissues in the brain, due to changes in 
dielectric properties as a result of plaques and tangles, 
therefore indicating the current stage of AD in the brain. Data 
from the experimental results were also used in the MIST 
imaging algorithm to reconstruct images showing different 
levels of plaques and tangles in the brain. The resulting images 
are promising as they confirm that plaques and tangles could 
be detected and displayed using the data captured in the 
experiments. In addition, these images provide a promising 
non-invasive technique to detect plaques and tangles as 
compared to PET scans.  
The results from this novel research provide a strong 
foundation for future work to be done in investigating how 
EM or RF sensing techniques can be utilized for detecting and 
monitoring Alzheimer’s disease in a patient. In particular, 
comparing and validating the measurements and images 
generated from this technique with those obtained from 
functional MRIs (fMRIs) and PET scans could provide a 
significant opportunity in translating this novel approach as a 
Fig. 16. Reconstructed images of the four volumes of AD-affected brain tissues in the brain phantom using the MIST 
algorithm (bottom row) along with the actual pictures of the objects and their placements in the brain phantom (top row). 
 
future wearable diagnostic tool for patients with Alzheimer’s 
disease, as well as other brain conditions, that is potentially 
affordable, accessible, and comfortable.  
Future work will be focused on optimizing the RF sensor 
design and imaging algorithm further, developing more 
sophisticated brain phantoms that replicate the complex 
geometries and layers of an actual human brain, and 
developing more realistic experiments that emulate the 
different stages of AD. Factors, such as the bending of the 
antenna and noise in the environment, may have played a role 
in the measured S11 response in this work. These will also 
need to be investigated to further validate the sensitivity, 
accuracy, and resolution of the RF sensors and whether it is 
suitable for non-invasive detection and monitoring of 
Alzheimer’s disease in the brain.   
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